Medint Medical Intelligence ltd.

What Medint Medical Intelligence ltd. does

Medint Medical Intelligence Ltd. (dba MedINT) is an Israel-based healthcare technology company that operates an AI-powered clinical evidence synthesis platform aimed at licensed physicians. The platform allows clinicians to submit clinical questions and receive synthesized answers drawn from peer-reviewed medical literature, with the goal of accelerating evidence-based decision-making at the point of care. The company is headquartered in Tel Aviv at 114 Yigal Alon Street, with secondary presence in the UK and the United States.\n\nThe product portfolio consists of two distinct offerings. The first, MedINT Search, is a free AI-driven search tool that surfaces answers from the medical literature. The second, Human-Led Deep Research, is a paid service priced at $150 per question, where clinical questions are routed to a panel of senior physicians and researchers and answered within 24 hours. The platform also exposes a Visual Dashboard for reporting and AI Conclusion Summaries to digest findings. Underlying technology relies on text-based natural language processing and retrieval from medical literature, with a human-in-the-loop editorial layer that combines AI inference with expert physician review.\n\nThe business model is self-serve, product-led, and transaction-based, with pricing disclosed only for the Human-Led Deep Research tier. The company serves a single customer segment — licensed physicians — across Israel, the UK, and the US. The team is small, with approximately 25 members including named physicians and researchers, and the firm is actively hiring Medical Researcher and Physician-Researcher roles in Tel Aviv. No funding rounds, partnerships, acquisitions, or revenue figures have been publicly disclosed.

Name

Medint Medical Intelligence ltd.

Legal name

MedInt Ltd.

Website

https://medint.ai

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Medint Medical Intelligence (MedINT) is an Israel-based company that provides an AI-powered clinical evidence synthesis platform for licensed physicians, combining a free AI Search tool with a paid Human-Led Deep Research service priced at $150 per question.

Ownership category

akta.pro rank

Headquarters

HQ city

Tel Aviv

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Per-Research Transaction: Transaction-based pricing at $150 per research question for the Human-Led Deep Research service. Users pay per query without subscription commitments. The Search feature appears to be available separately with different access terms.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Medint (MedINT) provides a clinical decision support platform for healthcare professionals, offering AI-powered medical search and a Human-Led Deep Research service that synthesizes medical information on demand. The company was founded by physicians and delivers its offering through a self-serve online chat interface where users can submit clinical questions and receive research-backed answers.

Product overview

MedINT is a healthcare AI platform that provides human-guided AI insights for complex clinical decision-making. The platform consists of two main service offerings: Search (a rapid, clinician-supervised evidence lookup for focused clinical questions) and Human-Led Deep Research (a comprehensive, human-guided investigation for complex cases priced at $150 per research question). Both services deliver AI-generated outputs including Conclusion summaries, Evidence Says summaries, and visual dashboards synthesized from published medical and scientific literature. The platform is designed exclusively for licensed healthcare professionals and emphasizes human-in-the-loop control with clinician oversight.

Differentiator

Problem solved

Functional benefit

Products and services

• Medint Search

Quantifiable outcome

• Delivers patient-specific intelligence in a fraction of the time compared to traditional research methods

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Scale indicators3 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• Glass Health: AI clinical decision support platform for physicians that drafts clinical plans and synthesizes medical evidence. Closely comparable to MedINT on use case and target customer (licensed clinicians) and AI-first clinical evidence workflow.
• OpenEvidence: AI-powered clinical evidence synthesis platform that serves US physicians with point-of-care answers derived from peer-reviewed literature. Most direct competitor to MedINT on AI-generated, patient-specific clinical evidence for licensed clinicians.

Emerging players

• VisualDx: Clinical decision support system focused on differential diagnosis and image-based clinical reasoning. Comparable to MedINT on AI-assisted clinical decision support for licensed clinicians, though narrower in modality (visual/diagnostic).
• Elicit: AI research assistant that searches and synthesizes scientific literature for clinicians and researchers. Comparable to MedINT on AI literature synthesis, though domain generalist rather than clinical-specific.
• Syllable (Sully.ai): AI medical assistant for clinicians that automates documentation, triage, and clinical decision support. Comparable to MedINT as an emerging AI tool targeting physician workflows, though broader in scope beyond evidence synthesis.
• Consensus (formerly Consensus NLP): AI-powered academic search engine that synthesizes peer-reviewed literature into evidence-based answers. Comparable to MedINT on AI-driven evidence synthesis methodology, though serves a broader audience including researchers and laypersons beyond physicians.
• Hippocratic AI: AI company building safety-focused large language models for healthcare, including clinical decision support and patient-facing use cases. Comparable to MedINT as an emerging AI clinical evidence player targeting similar clinician workflows.

Broad incumbents

• BMJ Best Practice: International clinical decision support tool from BMJ providing evidence-based point-of-care information. Comparable to MedINT on use case (physician evidence lookup) but with global institutional footprint and decades of curated content.
• UpToDate (Wolters Kluwer): Dominant subscription-based clinical decision support resource used by most US hospitals and physicians. Overlaps with MedINT on clinician-targeted evidence synthesis but operates at vastly larger scale via institutional subscriptions and EHR integration.
• DynaMed (EBSCO): Evidence-based clinical decision support tool used by physicians at the point of care. Directly competes with MedINT on clinician-targeted evidence synthesis, but as a mature, broadly adopted incumbent with institutional distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medint Medical Intelligence ltd.